Harmonized System Codes • Schedule B • Harmonized Commodity Description

HS Code 29094905: Guaifenesin - An Essential Ingredient in Cough Medicines

When it comes to treating coughs and congestion, one of the key ingredients found in many over-the-counter cough medicines is Guaifenesin. This active pharmaceutical ingredient plays a vital role in relieving chest congestion by loosening and thinning mucus in the airways. Guaifenesin is classified under HS Code 29094905, which specifically covers this compound.

Guaifenesin is used in both liquid and tablet forms and is commonly found in cough syrups, expectorants, and combination cold medications. It has been approved by regulatory authorities around the world for its effectiveness in alleviating symptoms associated with respiratory conditions.

HS Code 29094905 - Product Description

• Product Name: Guaifenesin
• HS Code: 29094905

Bound / MFN Duty Rate

Under the principles of free trade, countries are encouraged to lower trade barriers and open up their markets. As a result, the bound or Most Favored Nation (MFN) duty rate for Guaifenesin is set at zero. This means that every time a country reduces trade barriers, it must provide the same duty-free treatment to all its trading partners for this specific product.

Quantity Unit

Guaifenesin is typically measured in kilograms (KG) for import and export purposes. This standardized unit of measurement allows for efficient trade and accurate record-keeping of the quantity of Guaifenesin being traded.

Special Tariff Preference Programs

In addition to the MFN duty rate, Guaifenesin also enjoys duty-free treatment under various special tariff preference programs. These programs include:

• Generalized System of Preferences (GSP): This program provides duty-free treatment for Guaifenesin and other eligible products from participating countries.
• Australia Special Rate: Guaifenesin imported from Australia is subject to a special rate, allowing for reduced or eliminated duties.
• Caribbean Basin Initiative (CBI): Guaifenesin imported from countries participating in the CBI program receives duty-free treatment.
• Israel Special Rate: Guaifenesin imported from Israel benefits from duty-free treatment.
• Andean Trade Preference Act (ATPA): Guaifenesin imported from ATPA beneficiary countries is eligible for duty-free treatment.
• Jordan Special Rate: Guaifenesin imported from Jordan is subject to a special rate, allowing for reduced or eliminated duties.
• Mexico Special Rate: Guaifenesin imported from Mexico under the NAFTA agreement receives duty-free treatment.
• Oman Special Rate: Guaifenesin imported from Oman is subject to a special rate, allowing for reduced or eliminated duties.
• Dominican Republic-Central American Special Rate (DR-CAFTA): Guaifenesin imported from DR-CAFTA countries benefits from duty-free treatment.
• Peru Special Rate: Guaifenesin imported from Peru is subject to a special rate, allowing for reduced or eliminated duties.
• Singapore Special Rate: Guaifenesin imported from Singapore is eligible for duty-free treatment.

Importing and Exporting US States

Guaifenesin is imported and exported between various states in the United States. The specific states involved in trade may vary depending on factors such as production facilities, distribution networks, and consumer demand. Some of the major importing and exporting states for Guaifenesin in the US include:

• Importing States: California, Texas, New York, Florida, Illinois
• Exporting States: Ohio, North Carolina, Pennsylvania, Indiana, Georgia

Guaifenesin, classified under HS Code 29094905, plays a crucial role in the formulation of cough medicines and expectorants. Its effectiveness in relieving congestion and promoting easier breathing has made it a popular ingredient in over-the-counter medications worldwide. With its duty-free status and participation in various special tariff preference programs, Guaifenesin enjoys facilitated trade between countries, ensuring that individuals suffering from respiratory conditions can access the relief they need.